Novel control of S phase of the cell cycle by ubiquitin-conjugating enzyme H7

Molecular Biology of the Cell

Volumn 20, Issue 1, 2009, Pages 1-9

  Whitcomb, Elizabeth A ^a   Dudek, Edward J ^a   Liu, Qing ^a   Taylor, Allen ^a,b  

^a TUFTS UNIVERSITY   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHECKPOINT KINASE 1; UBIQUITIN CONJUGATING ENZYME; UBIQUITIN CONJUGATING ENZYME H7; UNCLASSIFIED DRUG; CHECKPOINT KINASE 2; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEASOME; PROTEIN KINASE; PROTEIN SERINE THREONINE KINASE; PTEN PROTEIN, HUMAN; UBE2L3 PROTEIN, HUMAN; UBIQUITIN;

ARTICLE; CELL CYCLE G2 PHASE; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL LEVEL; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME DEGRADATION; GENE EXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; CELL CYCLE; CELL LINE; GENE SILENCING; GENETICS; METABOLISM; PHYSIOLOGY;

ANIMALS; CELL CYCLE; CELL LINE; GENE KNOCKDOWN TECHNIQUES; HUMANS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; PTEN PHOSPHOHYDROLASE; S PHASE; UBIQUITIN; UBIQUITIN-CONJUGATING ENZYMES;

EID: 63049130207     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E08-01-0036     Document Type: Article

References (44)

1. Anan, T. et al. (1998). Human ubiquitin-protein ligase Nedd4, expression, subcellular localization and selective interaction with ubiquitin-conjugating enzymes. Genes Cells 3, 751-763.
2. Bastians, H., Topper, L. M., Gorbsky, G. L., and Ruderman, J. V. (1999). Cell cycle-regulated proteolysis of mitotic target proteins. Mol. Biol. Cell 10, 3927-3941.
3. Bornstein, G., Bloom, J., Sitry-Shevah, D., Nakayama, K., Pagano, M., and Hershko, A. (2003). Role of the SCFSkp2 ubiquitin ligase in the degradation of p21Cip1 in S phase. J. Biol. Chem. 278, 25752-25757.
4. Brzovic, P. S., Keeffe, J. R., Nishikawa, H., Miyamoto, K., Fox, D., 3rd, Fukuda, M., Ohta, T., and Klevit, R. (2003). Binding and recognition in the assembly of an active BRCA1/BARD1 ubiquitin-ligase complex. Proc. Natl. Acad. Sci. USA 100, 5646-5651.
5. Carrano, A. C., Eytan, E., Hershko, A., and Pagano, M. (1999). SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat. Cell Biol. 1, 193-199.
6. Cory, A. H., Owen, T. C., Barltrop, J. A., and Cory, J. G. (1991). Use of an aqueous soluble tretrazolium/formazan assay for cell growth assays in culture. Cancer Comm. 7, 207-212.
7. Fortier, J. M., and Kornbluth, J. (2006). NK lytic-associated molecule, involved in NK cytotoxic function, is an E3 ligase. J. Immunol. 176, 6454-6463.
8. Fouladkou, F., Landry, T., Kawabe, H., Neeb, A., Lu, C., Brose, N., Stambolic, V., and Rotin, D. (2008). The ubiquitin ligase Nedd4-1 is dispensable for the regulation of PTEN stability and localization. Proc. Natl. Acad. Sci. USA 105, 8585-8590.
9. Geetha, T., Kenchappa, R. S., Wooten, M. W., and Carter, B. D. (2005). TRAF6-mediated ubiquitination regulates nuclear translocation of NRIF, the p75 receptor interactor. EMBO J. 24, 3859-3868.
10. Harbers, K., Muller, U., Grams, A., Li, E., Jaenisch, R., and Franz, T. (1996). Provirus integration into a gene encoding a ubiquitin-conjugating enzyme results in a placental defect and embryonic lethality. Proc. Natl. Acad. Sci. USA 93, 12412-12417.
11. Hershko, A., and Ciechanover, A. (1998). The ubiquitin system. Annu. Rev. Biochem. 67, 425-479.
12. Hough, R., and Rechsteiner, M. (1986). Ubiquitin-lysozyme conjugates. Purification and susceptibility to proteolysis. The J. Biol. Chem. 261, 2391-2399.
13. Huang, L., Kinnucan, E., Wang, G., Beaudenon, S., Howley, P. M., Huibregtse, J. M., and Pavletich, N. P. (1999). Structure of an E6AP-UbcH7 complex: insights into ubiquitination by the E2-E3 enzyme cascade. Science 286, 1321-1326.
14. Liu, Q. et al. (2000). Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/MDNA damage checkpoint. Genes Dev. 14, 1448-1459.
15. Liu, Q., Shang, F., Guo, W., Hobbs, M., Valverde, P., Reddy, V., and Taylor, A. (2004). Regulation of the ubiquitin proteasome pathway in human lens epithelial cells during the cell cycle. Exp. Eye Res. 78, 197-205.
16. Liu, Q., Shang, F., Whitcomb, E., Guo, W., Li, W., and Taylor, A. (2006). Ubiquitin-conjugating enzyme 3 delays human lens epithelial cells in metaphase. Invest. Ophthalmol. Vis. Sci. 47, 1302-1309.
17. Marteijn, J. A., van Emst, L., Erpelinck-Verschueren, C. A., Nikoloski, G., Menke, A., de Witte, T., Lowenberg, B., Jansen, J. H., and van der Reijden, B. A. (2005). The E3 ubiquitin-protein ligase Triad1 inhibits clonogenic growth of primary myeloid progenitor cells. Blood 106, 4114-4123.
18. Nuber, U., Schwarz, S. E., and Scheffner, M. (1998). The ubiquitin-protein ligase E6-associated protein (E6-AP) serves as its own substrate. Eur. J. Bio-chem. 254, 643-649.
19. Ogunjimi, A. A., Briant, D. J., Pece-Barbara, N., Le Roy, C., Di Guglielmo, G. M., Kavsak, P., Rasmussen, R. K., Seet, B. T., Sicheri, F., and Wrana, J. L. (2005). Regulation of Smurf2 ubiquitin ligase activity by anchoring the E2 to the HECT domain. Mol. Cell 19, 297-308.
20. Oh, K. J., Kalinina, A., Wang, J., Nakayama, K., Nakayama, K. I., and Bagchi, S. (2004). The papillomavirus E7 oncoprotein is ubiquitinated by UbcH7 and Cullin 1- and Skp2-containing E3 ligase. J. Virol. 78, 5338-5346.
21. Peters, J. M. (2002). The anaphase-promoting complex: proteolysis in mitosis and beyond. Mol. Cell 9, 931-943.
22. Pickart, C. M., and Fushman, D. (2004). Polyubiquitin chains: polymeric protein signals. Curr. Opin. Chem. Biol. 8, 610-616.
23. Pines, J., and Lindon, C. (2005). Proteolysis: anytime, any place, anywhere? Nat. Cell Biol. 7, 731-735.
24. Pringa, E., Meier, I., Muller, U., Martinez-Noel, G., and Harbers, K. (2000). Disruption of the gene encoding the ubiquitin-conjugating enzyme UbcM4 has no effect on proliferation and in vitro differentiation of mouse embryonic stem cells. Biochim. Biophys. Acta 1494, 75-82.
25. Puc, J. et al. (2005). Lack of PTEN sequesters CHK1 and initiates genetic instability. Cancer Cell 7, 193-204.
26. Rape, M., and Kirschner, M. W. (2004). Autonomous regulation of the an-aphase-promoting complex couples mitosis to S-phase entry. Nature 432, 588-595.
27. Rape, M., Reddy, S. K., and Kirschner, M. W. (2006). The processivity of multiubiquitination by the APC determines the order of substrate degradation. Cell 124, 89-103.
28. Sage, J., Miller, A. L., Perez-Mancera, P. A., Wysocki, J. M., and Jacks, T. (2003). Acute mutation of retinoblastoma gene function is sufficient for cell cycle re-entry. Nature 424, 223-228.
29. Shang, F., Deng, G., Obin, M., Wu, C. C., Gong, X., Smith, D., Laursen, R. A., Andley, U. P., Reddan, J. R., and Taylor, A. (2001). Ubiquitin-activating enzyme (E1) isoforms in lens epithelial cells: origin of translation, E2 specificity and cellular localization determined with novel site-specific antibodies. Exp. Eye Res. 73, 827-836.
30. Shimura, H. et al. (2000). Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat. Genet. 25, 302-305.
31. Shtivelman, E., Sussman, J., and Stokoe, D. (2002). A role for PI 3-kinase and PKB activity in the G2/M phase of the cell cycle. Curr. Biol. 12, 919-924.
32. Sorensen, C. S., Syljuasen, R. G., Falck, J., Schroeder, T., Ronnstrand, L., Khanna, K. K., Zhou, B. B., Bartek, J., and Lukas, J. (2003). Chk1 regulates the S phase checkpoint by coupling the physiological turnover and ionizing radiation-induced accelerated proteolysis of Cdc25A. Cancer Cell 3, 247-258.
33. Staropoli, J. F., McDermott, C., Martinat, C., Schulman, B., Demireva, E., and Abeliovich, A. (2003). Parkin is a component of an SCF-like ubiquitin ligase complex and protects postmitotic neurons from kainate excitotoxicity. Neuron 37, 735-749.
34. Tashtoush, B. M., Traboulsi, A. A., Dittert, L., and Hussain, A. A. (2001). Chloramine-T in radiolabeling techniques. IV. Penta-O-acetyl-N-chloro-N- methylglucamine as an oxidizing agent in radiolabelling techniques. Anal. Biochem. 288, 16-21.
35. Torres, J., and Pulido, R. (2001). The tumor suppressor PTEN is phosphory-lated by the protein kinase CK2 at its C terminus. Implications for PTEN stability to proteasome-mediated degradation. J. Biol. Chem. 276, 993-998.
36. Tsvetkov, L. M., Yeh, K. H., Lee, S. J., Sun, H., and Zhang, H. (1999). p27(Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylated Thr187 in p27. Curr. Biol. 9, 661-664.
37. Verma, S., Ismail, A., Gao, X., Fu, G., Li, X., O'Malley, B. W., and Nawaz, Z. (2004). The ubiquitin-conjugating enzyme UBCH7 acts as a coactivator for steroid hormone receptors. Mol. Cell. Biol. 24, 8716-8726.
38. Waite, K. A., and Eng, C. (2003). BMP2 exposure results in decreased PTEN protein degradation and increased PTEN levels. Hum. Mol. Genet. 12, 679-684.
39. Wang, X. et al. (2007). NEDD4-1 is a proto-oncogenic ubiquitin ligase for PTEN. Cell 128, 129-139.
40. Yew, P. R. (2001). Ubiquitin-mediated proteolysis of vertebrate G1- and S-phase regulators. J. Cell. Physiol. 187, 1-10.
41. Yokouchi, M., Kondo, T., Houghton, A., Bartkiewicz, M., Horne, W. C., Zhan, H., Yoshimura, A., and Baron, R. (1999). Ligand-induced ubiquitination of the epidermal growth factor receptor involves the interaction of the c-Cbl RING finger and ubcH7. J. Biol. Chem. 274, 31707-31712.
42. Yu, Z. K., Gervais, J. L., and Zhang, H. (1998). Human CUL-1 associates with the SKP1/SKP2 complex and regulates p21(CIP1/WAF1) and cyclin D proteins. Proc. Natl. Acad. Sci. USA 95, 11324-11329.
43. Zhang, Y., Otterness, D., Chiang, G., Xie, W., Liu, Y., Mercurio, F., and Abraham, R. (2005). Genotoxic stress targets human Chk1 for degradation by the ubiquitin-proteasome pathway. Mol. Cell 19, 607-618.
44. Zheng, N., Wang, P., Jeffrey, P. D., and Pavletich, N. P. (2000). Structure of a c-Cbl-UbcH7 complex: RING domain function in ubiquitin-protein ligases. Cell 102, 533-539.